While visual plasticity is strongest in early infancy, new studies show that plasticity is maintained well into adult life. This possibility is compellingly demonstrated by one patient, SK, who gained vision for the first time in adult life and significantly improved his ability to see the world around him. The persistence of visual plasticity in adults is promising news for the developing field of visual prosthesis.
The goal of visual prosthesis is to allow functional restoration of vision and to improve quality of life for blind patients. In order to achieve these goals, the prosthetic devices must tap into the brain's plasticity. Plasticity is how the brain adapts to new environmental stimuli. It enables all forms of learning, including memorizing facts, playing the piano, and learning to see. Specifically, plasticity is how neural networks in the brain reorganize in response to new experiences. Understanding plasticity furthers insight into the brain mechanisms active in visual prostheses, and may help scientists develop new approaches for future devices.
VISUAL PLASTICITY
I n normally sighted people, learning to see takes place in early childhood. The "critical periods" theory of brain development states that normal function requires sensory input during a short period of development, usually in the first weeks or months of life. During this critical period, the brain exhibits maximum plasticity. If the system does not receive normal input during the critical period, irreversible developmental defects may occur because the brain loses its plasticity (Carroll 2009 ). For the visual system, this may imply that vision cannot be restored after deprivation during the critical period. If this were the case, it would severely limit the potential use of visual prosthetic devices in congenitally blind adults.
While much research has demonstrated evidence of visual critical periods, other studies have shown significant retained visual plasticity in the adult brain. These studies observed patients with dense bilateral congenital cataracts after correction. In developed countries, these patients are treated in the first year of life, leading to good restoration of visual function. However, in less-developed countries, some of these patients remain untreated as adults. In current clinical practice, congenital cataract operations are rarely completed on children older than five or six due to the belief that little visual function can be restored after that age (Ostrovsky et al. 2009 ). However, emerging evidence now points toward the utility of treating adult patients.
Several studies have found evidence of visual critical periods in patients treated for dense bilateral congenital cataracts. Patients treated within the first year of life retained subtle visual deficits from this early period of blindness. One study demonstrated lifelong deficits in visual acuity, especially when viewing high-frequency stimulation, such as stripes close together (Maurer et al. 2007) . Another study showed visual impairments resulting from longer periods of blindness (Putzar et al. 2007) . When looking at a simple optical-illusion type test, patients treated for cataracts after six months of age had problems perceiving visual illusory contours compared to normal controls. However, patients who were treated prior to six months of age performed the same tests with normal accuracy and speed (Putzar et al. 2007 ). This evidence suggests the existence of critical periods for different aspects of visual plasticity. However, the defects resulting from these short sensory deprivations are mild, suggesting that critical periods are far from absolute. Although the brain has heightened plasticity during the critical period, it does retain significant plasticity afterward, allowing it to partially recover from early insults.
Several case studies show evidence for retained visual plasticity during adulthood. Most patients with dense bilateral congenital cataracts are treated when they are infants, and therefore it is difficult to find untreated adults. Professor Sinha's lab at the Massachusetts Institute of Technology seeks these rare cases. Project From Visual Plasticity to the Bionic Eye Prakash, one of Sinha's projects, is a charitable organization that searches for congenitally blind children in India, treats their conditions, and follows their visual development.
One of Sinha's patients, SRD, was treated for dense bilateral congenital cataracts at age 12. SRD showed significant improvement in visual function and quality of life after surgery. Before surgery, SRD could tell the difference only between night and day. She was unable to see people or objects in her environment and did not leave the house alone. Within six months after surgery, SRD had learned to recognize her family members, and after one year she was able to recognize objects. Twenty years after surgery, she continued to show visual deficits, including low visual acuity (20/200), and some deficits in laboratory tasks such as face recognition and gaze estimation (Ostrovsky et al. 2006) . Although SRD did not achieve completely normal vision, perhaps from her extended blindness during a critical period, her significant improvement indicates that her brain retained functional plasticity in early adolescence.
Another patient of Sinha, SK, had congenital bilateral aphakia (absence of the lenses in both eyes) and was fitted for eyeglasses at the age of 29. Previously he was unable to afford a pair of glasses. Two weeks after he received his glasses, SK was able to discriminate color, luminance, and direction of motion (Ostrovsky et al. 2009 ).
When viewing images through his new eyeglasses, SK continued to show severe impairment. For example, when he looked at two overlapping squares, he inaccurately perceived three objects. Sinha observed that when naming and tracing pictures of everyday objects, SK oversegmented the images and "partitioned them into meaningless regions" (Ostrovsky et al. 2009 ). This evidence suggests that perceiving objects as a unified whole is a learned skill. When SK added motion to these tasks it greatly increased his ability to determine the number of objects. For example, a circle and a square moving through each other became two objects instead of three. These data suggest that motion is an important part of learning to see objects in a nonfragmentary manner. Moreover, visual motion may be an important way that the brain learns to see, at least in adults (Ostrovsky et al. 2009 ).
Over time, SK showed improvement on visual tasks. After 18 months, he could determine the number of objects in a scene (for example, the two overlapping squares) with ninety percent accuracy. SK's improvement demonstrates that learning took place, implying that plasticity is still active in the adult brain. Because SK is 29 years old, he is far from the traditionally defined visual critical period. His improvement presents a compelling argument for treating adults with reversible congenital blindness. Additionally, the persistence of plasticity in adult life is promising for the future development of visual prosthetic devices, since such devices may require a significant amount of learning in order to be used effectively.
While congenital cataracts are easily treated with surgery, many other causes of blindness currently have few efficacious treatments. For such patients, visual prosthesis offers new options for future treatment.
PROSTHETIC DEVICES
Currently, many research groups are working on visual prosthetic devices and several are in the early stages of clinical trials. Different approaches to visual prosthesis include stimulating electrodes located in the sclera, the retina, the optic nerve, and the visual cortex.
The most successful research thus far has focused on retinal implants. Such devices have shown promise in patients with retinal degenerative diseases such as agerelated macular degeneration and retinitis pigmentosa. These diseases primarily affect the rod-and-cone photoreceptors of the eye. Generally, these ailments do not impair the ganglion cells that send the visual signals to cortex via the optic nerve. Researchers conjecture that by stimulating damaged areas of the retina, they can excite ganglion cells, which transmit signals back to the brain. However, the actual mechanism by which stimulating electrodes affect the cortex remains unknown (Chader et al. 2009 ).
One company, Second Sight Medical Products, began Phase 1 clinical trials in 2002 using an implanted electrode array. Sixteen electrodes were implanted epiretinally on top of the ganglion cells. A camera was mounted on the patient's glasses to capture an image of the world, pixilize the image, and wirelessly transmit the data to the electrodes. The electrodes stimulated various parts of the retina based on camera input, and were found to be safe for patients to use. Additionally, patients using the device reported restored light perception and saw phosphenes when electrodes were experimentally stimulated. After a period of learning, patients became more efficient at using their devices. With the camera, patients learned to sense the level of ambient light and could sense the direction of motion of a bar of light in front of the camera. Most excitingly, patients could distinguish among a plate, a knife, and a cup presented against a dark background. Currently, Second Sight Medical Products is testing a 60-electrode array in Phase 2 clinical trials. Ideally, this higher density of electrodes should allow better object discrimination (Chader et al. 2009 ).
One drawback to retinal devices is that they require intact ganglion cells and a functioning optic nerve to allow transmission to the visual cortex. Cortical implants 4Medical Review have the advantage of being potentially useful in patients with dysfunctions of the optic nerve, which can be caused by diabetic retinopathy or glaucoma. Stimulating microelectrodes in the human visual cortex have been shown to elicit perceptions of phosphenes. Monkeys can be trained to reach to areas of their visual fields that correspond with cortical areas stimulated by implanted electrodes (Weiland and Humayun 2008) .
As research continues in visual prosthetics, we will learn more about brain plasticity and how it can interact with mechanical devices to help restore vision. Already, the patients in the Second Sight Medical Products trial markedly improved their visual abilities after a learning period, suggesting that visual plasticity plays a large role in adapting to prosthetics. In this model, the brain needs time to learn to use the new electrical input. If plasticity does play an important role in prosthetics, it may potentially be manipulated to improve the efficacy of prosthetic devices. For example, patients receiving visual prostheses may also receive a drug or training technique that enhances plasticity. This combination may lead to even greater improvements in vision.
One possible way to improve plasticity is related to the observation that motion improved SK's ability to perceive objects. Perhaps training with moving stimuli may enhance plasticity in patients with prosthetic devices. Furthermore, studies with mice also suggest some methods to enhance plasticity. For example, mice that live in environments enriched with many toys and tunnels show improved vision recovery after experiments depriving one eye of visual input. However, exactly how to create an "enriched environment" for human patients is unclear. Another mouse study shows that fluoxetine (Prozac), a selective serotonin reuptake inhibitor, greatly improves recovery of vision in an eye that has been deprived of sight (Spolidoro et al. 2009 ). These ideas represent possible avenues for further research.
With the rapid pace of investigation into both visual prosthesis and cortical plasticity, scientists have the opportunity to develop new treatments for blindness and provide new insight into the complex functions of the human brain.
